LGC and AutoGen combine unique offerings for expanding markets
AutoGen and LGC have today announced a formalised distribution agreement, for the sale of AutoGen’s innovative FlexStar and Arrow platforms across Europe, the Middle East and Africa and their QuickGene platform in the Middle East and Africa.
Bob Sullivan, CEO, AutoGen, said, “This relationship is more than extending the reach of our individual product offerings. It’s about the alignment of two compelling missions. AutoGen is very pleased to be partnering with LGC Genomics as our new distributor in Europe. The combination of AutoGen's reliable nucleic acid systems and LGC's market presence and expertise in genomics will make a great team to serve both our new and existing customers in the European market. I am personally very excited to be working with such a high quality organization and happy that our customers will be served by a top notch company in the Life Science field.”
Giulio Cerroni, Managing Director, Genomics, LGC, said, “LGC has a great history of working with research and clinical scientists to increase the understanding of genetic markers in medical research. Through this new agreement, LGC and AutoGen will further enhance our combined efforts to enable scientists worldwide to enable workflow automation to extract high quality DNA and RNA preparations for downstream processing.”
LGC scientists have contributed significantly to the development of new genotyping technologies, making affordable projects accessible to a broad range of customers, independent of project size. To date, they have extracted DNA from over 10 million samples, as well as processed over 1 billion PCR reactions.